Skip to main content

US ClosedU.S. Closed

VBIO: Valion Bio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Valion Bio, Inc. operates as a late-stage biopharmaceutical company.

52W Range

1stpctl

Volume

0.55×avg

Market Cap

10.73MUSD

P/E Ratio

-0.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Valion Bio, Inc.

VBIONASDAQ·USD·Closed

Valion Bio, Inc.

VBIONASDAQ·USD·Closed

$2.59

+3.19%

$2.59

+$0.08 (3.19%)

52W Range

1stpctl

Volume

0.55×avg

Mkt Cap

10.73MUSD

P/E

-0.0TTM

Div Yield

–ann